X4 Pharmaceuticals (XFOR)
(Delayed Data from NSDQ)
$0.64 USD
+0.01 (0.94%)
Updated Aug 12, 2024 04:00 PM ET
After-Market: $0.63 -0.01 (-0.93%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.07 |
Last EPS Surprise | -40.00% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.53 |
Next Year | -0.44 |
EPS (TTM) | -0.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.79M | 5.12M | 24.76M | 51.45M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 3.50M | 10.40M | 115.55M | 140.70M |
Low Estimate | 0.75M | 1.22M | 2.50M | 9.33M |
Year ago Sales | 0.00M | 0.00M | NA | 24.76M |
Year over Year Growth Est. | NA | NA | NA | 107.82% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.16 | -0.53 | -0.44 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.17 | -0.12 | -0.21 | -0.10 |
High Estimate | -0.17 | -0.13 | -0.10 | -0.09 |
Low Estimate | -0.18 | -0.17 | -0.80 | -0.70 |
Year ago EPS | -0.01 | -0.10 | -0.57 | -0.53 |
Year over Year Growth Est. | -1,600.00% | -60.00% | 7.02% | 16.35% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 1 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.16 | -0.53 | -0.44 |
7 Days Ago | -0.17 | -0.15 | -0.55 | -0.45 |
30 Days Ago | -0.17 | -0.15 | -0.55 | -0.45 |
60 Days Ago | -0.17 | -0.15 | -0.55 | -0.44 |
90 Days Ago | -0.17 | -0.15 | -0.55 | -0.44 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.13 | -0.10 | -0.09 |
Zacks Consensus Estimate | -0.17 | -0.16 | -0.53 | -0.44 |
Earnings ESP | 0.00% | 16.13% | 81.13% | 79.70% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.07 | -0.26 | -0.10 | -0.01 | NA |
Estimate | -0.05 | -0.17 | -0.15 | -0.15 | NA |
Difference | -0.02 | -0.09 | 0.05 | 0.14 | 0.02 |
Surprise | -40.00% | -52.94% | 33.33% | 93.33% | 8.43% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more